Synaptojanin-2 Binding Protein Stabilizes the Notch Ligands DLL1 and DLL4 and Inhibits Sprouting Angiogenesis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Rationale: The formation of novel blood vessels is initiated by vascular endothelial growth factor. Subsequently, DLL4-Notch signaling controls the selection of tip cells, which guide new sprouts, and trailing stalk cells. Notch signaling in stalk cells is induced by DLL4 on the tip cells. Moreover, DLL4 and DLL1 are expressed in the stalk cell plexus to maintain Notch signaling. Notch loss-of-function causes formation of a hyperdense vascular network with disturbed blood flow. Objective: This study was aimed at identifying novel modifiers of Notch signaling that interact with the intracellular domains of DLL1 and DLL4. Methods and Results: Synaptojanin-2 binding protein (SYNJ2BP, also known as ARIP2) interacted with the PDZ binding motif of DLL1 and DLL4, but not with the Notch ligand Jagged-1. SYNJ2BP was preferentially expressed in stalk cells, enhanced DLL1 and DLL4 protein stability, and promoted Notch signaling in endothelial cells. SYNJ2BP induced expression of the Notch target genes HEY1, lunatic fringe (LFNG), and ephrin-B2, reduced phosphorylation of ERK1/2, and decreased expression of the angiogenic factor vascular endothelial growth factor (VEGF)-C. It inhibited the expression of genes enriched in tip cells, such as angiopoietin-2, ESM1, and Apelin, and impaired tip cell formation. SYNJ2BP inhibited endothelial cell migration, proliferation, and VEGF-induced angiogenesis. This could be rescued by blockade of Notch signaling or application of angiopoietin-2. SYNJ2BP-silenced human endothelial cells formed a functional vascular network in immunocompromised mice with significantly increased vascular density. Conclusions: These data identify SYNJ2BP as a novel inhibitor of tip cell formation, executing its functions predominately by promoting Delta-Notch signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467 · cited 4×
“ment as well as for tissue growth and wound healing in the adult.(1) Excessive angiogenesis is frequently observed in solid”
BackgroundInfluentialDll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.-C., Chanthery, Y., Kowalski, J., Watts, R. J., Callahan, C., Kasman, I., et al. (2006) · Nature · doi:10.1038/nature05313 · Cited by 986 · cited 2×
“This is of particular interest for antiangiogenic therapy, because Notch inhibition by blocking antibodies or γ-secretase inhibitors leads to excessive angiogenic sprouting and branching with a poorly functional vasculature.(10,11,45,46) The complexity of Notch signaling is mechanistically still poorly understood.”
BackgroundIdentification and functional analysis of endothelial tip cell–enriched genes
del Toro, R., Prahst, C., Mathivet, T., Siegfried, G., Kaminker, J. S., Larrivee, B., Breant, C., Duarte, A., Takakura, N., Fukamizu, A., et al. (2010) · Blood · doi:10.1182/blood-2010-02-270819 · Cited by 474
ALK1 Signaling Inhibits Angiogenesis by Cooperating with the Notch Pathway
Larrivée, B., Prahst, C., Gordon, E., del Toro, R., Mathivet, T., Duarte, A., Simons, M., & Eichmann, A. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.02.005 · Cited by 359 · cited 1×
“These oscillations determine time periods in which cells are responsive for tip or stalk cell–promoting factors.(15,16) Second, the expression of Notch ligands in tip and stalk cells is not a simple black-and-white situation.”
BackgroundChronic DLL4 blockade induces vascular neoplasms
Yan, M., Callahan, C. A., Beyer, J. C., Allamneni, K. P., Zhang, G., Ridgway, J. B., Niessen, K., & Plowman, G. D. (2010) · Nature · doi:10.1038/nature08751 · Cited by 280 · cited 1×
“Such continuous Notch signaling is necessary to prevent the conversion into the tip cell phenotype,(9) to allow further vessel remodeling,(18) and even to prevent angiogenesis in mature vessels.(12,13)”
BackgroundNotch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice
Liu, Z., Turkoz, A., Jackson, E. N., Corbo, J. C., Engelbach, J. A., Garbow, J. R., Piwnica-Worms, D. R., & Kopan, R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43114 · Cited by 119 · cited 1×
“Such continuous Notch signaling is necessary to prevent the conversion into the tip cell phenotype,(9) to allow further vessel remodeling,(18) and even to prevent angiogenesis in mature vessels.(12,13)”
BackgroundMatsuzaki, T., Hanai, S., Kishi, H., Liu, Z., Bao, Y., Kikuchi, A., Tsuchida, K., & Sugino, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112472200 · Cited by 85 · cited 3×
“SYNJ2BP regulates the localization of Synaptojanin-2 and the endocytosis of activin type II receptors.(19,20) This PDZ protein is widely expressed in mouse and rat tissues(20,21) and may play a role in cancer progression.”
BackgroundResult
Cited by
Hung, V., Lam, S. S., Udeshi, N. D., Svinkina, T., Guzman, G., Mootha, V. K., Carr, S. A., & Ting, A. Y. (2017) · eLife · doi:10.7554/elife.24463 · Cited by 372
Circulating microRNAs as novel biomarkers for platelet activation.
Willeit, P., Zampetaki, A., Dudek, K., Kaudewitz, D., King, A., Kirkby, N. S., Crosby-Nwaobi, R., Prokopi, M., Drozdov, I., Langley, S. R., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300539 · Cited by 365
Hartmann, C., Schwietzer, Y. A., Kummer, D., Kirschnick, N., Hoppe, E., Thüring, E.-M., Glaesner-Ebnet, M., Brinkmann, F., Gerke, V., Reuter, S., et al. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00274-1 · Cited by 32
TMIGD1: Emerging functions of a tumor supressor and adhesion receptor
Thüring, E.-M., Hartmann, C., Schwietzer, Y. A., & Ebnet, K. (2023) · Oncogene · doi:10.1038/s41388-023-02696-5 · Cited by 11
Metadata
- Authors
- Adam, M. G., Berger, C., Feldner, A., Yang, W.-J., Wüstehube-Lausch, J., Herberich, S. E., Pinder, M., Gesierich, S., Hammes, H.-P., Augustin, H. G., & Fischer, A.
- Venue
- Circulation Research
- Published
- 2013-11-08
- Volume
- 113
- Issue
- 11
- Pages
- 1206-1218
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2105238396
- Cited by
- 84
- References
- 9
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synaptojanin-2 Binding Protein Stabilizes the Notch Ligands DLL1 and DLL4 and Inhibits Sprouting Angiogenesis. https://app.cochat.ai/papers/10.1161/circresaha.113.301686
- The paper
- Adam, M. G., Berger, C., Feldner, A., Yang, W.-J., Wüstehube-Lausch, J., Herberich, S. E., Pinder, M., Gesierich, S., Hammes, H.-P., Augustin, H. G., & Fischer, A. (2013). Synaptojanin-2 Binding Protein Stabilizes the Notch Ligands DLL1 and DLL4 and Inhibits Sprouting Angiogenesis. Circulation Research. https://doi.org/10.1161/circresaha.113.301686
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.